The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro
about
A phase 1 clinical trial of sequential pralatrexate followed by a 48-hour infusion of 5-fluorouracil given every other week in adult patients with solid tumors.Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts.Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening
P2860
The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The impact of 5-formyltetrahyd ...... rexate, in HeLa cells in vitro
@en
The impact of 5-formyltetrahyd ...... exate, in HeLa cells in vitro.
@nl
type
label
The impact of 5-formyltetrahyd ...... rexate, in HeLa cells in vitro
@en
The impact of 5-formyltetrahyd ...... exate, in HeLa cells in vitro.
@nl
prefLabel
The impact of 5-formyltetrahyd ...... rexate, in HeLa cells in vitro
@en
The impact of 5-formyltetrahyd ...... exate, in HeLa cells in vitro.
@nl
P2093
P2860
P1476
The impact of 5-formyltetrahyd ...... rexate, in HeLa cells in vitro
@en
P2093
Ersin Selcuk Unal
I David Goldman
Michele Visentin
P2860
P2888
P304
P356
10.1007/S00280-014-2441-9
P577
2014-03-29T00:00:00Z